Fludarabine phosphate and Ureaplasma infection - from FDA reports
Ureaplasma infection is reported only by a few people who take Fludarabine Phosphate. We study 7,291 people who have side effects while taking Fludarabine phosphate from FDA. Among them, 4 have Ureaplasma infection. Find out below who they are, when they have Ureaplasma infection and more.
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our original studies have been referenced on 400+ peer-reviewed medical publications, including: The Lancet, and Mayo Clinic Proceedings.
7,291 people reported to have side effects when taking Fludarabine phosphate.
Among them, 4 people (0.05%) have Ureaplasma infection
Number of reports submitted per year:
Gender of people who have Ureaplasma infection when taking Fludarabine phosphate *:
- female: 0.0 %
- male: 100 %
Age of people who have Ureaplasma infection when taking Fludarabine phosphate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 100 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Top conditions involved for these people *:
- Diffuse Large B-Cell Lymphoma Stage Ii (cancer of b cells, a type of white blood cell-stage ii): 1 person, 25.00%
- Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 25.00%
- Bone Marrow Conditioning Regimen: 1 person, 25.00%
Top co-used drugs for these people *:
- Methylprednisolone: 4 people, 100.00%
- Methotrexate: 4 people, 100.00%
- Etoposide: 4 people, 100.00%
- Cisplatin: 4 people, 100.00%
- Cyclophosphamide: 3 people, 75.00%
Top other side effects for these people *:
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 100.00%
- Renal Failure Acute (rapid kidney dysfunction): 3 people, 75.00%
- Cytomegalovirus Infection: 3 people, 75.00%
- Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 3 people, 75.00%
- Acute Graft Versus Host Disease In Intestine (acute complication in intestine following an allogeneic tissue/blood transplant): 2 people, 50.00%
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Want to find out more about the FDA reports used in the study? You can request them from FDA.
Do you take Fludarabine phosphate and have Ureaplasma infection?
- Check whether a drug or a condition causes Ureaplasma infection
- Predict new side effects and undetected conditions
- Share you experience to help people like you
We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.
- Cbc (includes differential and platelets) ($32.00) Add to cart
- Cytomegalovirus (cmv) antibodies, igg ($92.00) Add to cart
- Cytomegalovirus (cmv) antibodies, quantitative, igm ($82.00) Add to cart
Fludarabine phosphate has active ingredients of fludarabine phosphate. (latest outcomes from Fludarabine phosphate 7,298 users)
Ureaplasma infection has been reported by people with hiv infection, immunodeficiency disorders, crohn's disease, staphylococcal infection, bacterial infection (latest reports from 65 Ureaplasma infection patients).
Drugs that are associated with Ureaplasma infectionUreaplasma infection (41 drugs)
Could your condition cause Ureaplasma infectionUreaplasma infection (34 conditions)
Expand the study to include all drugs with the same ingredientsUreaplasma infection and drugs with ingredients of fludarabine phosphate.
Expand the study to include reports from both FDA and eHealthMeUreaplasma infection and Fludarabine phosphate from FDA and eHealthMe reports (4 reports)
Fludarabine phosphate side effects
- Fludarabine phosphate side effects (7,291 reports)
Browse all side effects of Fludarabine phosphatea b c d e f g h i j k l m n o p q r s t u v w x y z
Analysis tools (to study 684 million drug outcomes from FDA)
- Check symptoms - identify the cause of a symptom: from a drug or from a condition?
- Check drugs - find out common side effects or drug interactions of my drugs.
- Compare drugs - compare the side effects and efficacy of multiple drugs side by side.
What would happen?
You are not alone. Join our personalized support groups:
- Support group for people who take Fludarabine Phosphate and have Ureaplasma Infection
- Support group for people who have Ureaplasma Infection
- Support group for people who take Fludarabine Phosphate
- Will you have Amyotrophic Lateral Sclerosis with Chymotrypsin?
- Will you have Paranasal Sinus Discomfort with Chymotrypsin?
- Will you have Nail Atrophy with Acute Brain Syndrome?
- Warfarin Sodium and Synalar drug interaction
- Will you have Eye Color Change with Humira?
Active Support Groups
- Support group for people who take Chymotrypsin and have Amyotrophic Lateral Sclerosis?
- Support group for people who take Chymotrypsin and have Paranasal Sinus Discomfort?
- Support group for people who have Acute Brain Syndrome and Nail Atrophy?
- Support group for people who take Warfarin Sodium and Synalar
- Support group for people who take Humira and have Eye Color Change?
- What to expect when you take Chymotrypsin and have Amyotrophic Lateral Sclerosis?
- What to expect when you take Chymotrypsin and have Paranasal Sinus Discomfort?
- What to expect when you have Acute Brain Syndrome and Nail Atrophy?
- What to expect when you take Warfarin Sodium and Synalar
- What to expect when you take Humira and have Eye Color Change?
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.